Find your next
research compound.
Featured Compounds
910463-68-2Semaglutide
GLP-1 Receptor Agonist
Also: Ozempic, Wegovy
A long-acting GLP-1 analog distinguished by its C18 fatty diacid chain, enabling albumin binding and a half-life of ~7 days. One of the most clinically studied peptides in modern metabolic research.
2023788-19-2Tirzepatide
GIP / GLP-1 Dual Agonist
Also: Mounjaro, Zepbound
A 39-amino acid synthetic peptide that simultaneously activates GIP and GLP-1 receptors. Demonstrated greater weight loss than any approved single-agonist in clinical trials.
2381089-83-2Retatrutide
GLP-1 / GIP / Glucagon Triple Agonist
Also: LY3437943
A novel triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously — the first of its kind in human Phase 2 trials. Early data suggests it may surpass dual agonists.
1448498-00-7MOTS-c
Mitochondrial Open Reading Frame of the 12S rRNA-c
Also: Mitochondrial-Derived Peptide, MDP
A 16-amino acid peptide encoded within the mitochondrial genome — a newly discovered class of signaling molecule. Regulates metabolic homeostasis via AMPK and FOXO1 pathways.